Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations

Cancer Letters

Volumn 228, Issue 1-2, 2005, Pages 247-255

  Lindskog, Magnus ^a   Spenger, Christian ^b,c   Klason, Tomas ^b,c   Jarvet, Jüri ^d   Gräslund, Astrid ^d   Johnsen, John Inge ^a   Ponthan, Frida ^a   Douglas, Lena ^a   Nordell, Bo ^a   Kogner, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Magnetic resonance; Necrosis; Neuroblastoma; Spectroscopy; Therapy

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CHOLINE; CISPLATIN; ETOPOSIDE; IRINOTECAN; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; POLYUNSATURATED FATTY ACID;

ANTINEOPLASTIC ACTIVITY; BIOCHEMISTRY; CANCER CHEMOTHERAPY; CELL DEATH; CLINICAL EXAMINATION; DRUG EFFECT; EVALUATION; HUMAN; IN VIVO STUDY; NEUROBLASTOMA; NONHUMAN; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SHORT SURVEY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR NECROSIS; TUMOR REGRESSION;

EID: 23944437368     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.055     Document Type: Review

References (56)

1. C. Hugosson, R. Nyman, H. Jorulf, P. McDonald, A. Rifai, A. Kofide, and B. Jacobsson Imaging of abdominal neuroblastoma in children Acta Radiol. 40 1999 534 542
2. M.J. Siegel, H. Ishwaran, B.D. Fletcher, J.S. Meyer, F.A. Hoffer, and D. Jaramillo Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group Radiology 223 2002 168 175
3. B.H. Kushner Neuroblastoma: a disease requiring a multitude of imaging studies J. Nucl. Med. 45 2004 1172 1188
4. H. Shimada, I.M. Ambros, L.P. Dehner, J. Hata, V.V. Joshi, and B. Roald The International Neuroblastoma Pathology Classification (the Shimada system) Cancer 86 1999 364 372
5. G.J. Lonergan, C.M. Schwab, E.S. Suarez, and C.L. Carlson Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation Radiographics 22 2002 911 934
6. B. Frostad, E. Tani, P. Kogner, S. Maeda, O. Bjork, and L. Skoog The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours Eur. J. Cancer 34 1998 529 536
7. A. Garaventa, B. De Bernardi, C. Pianca, A. Donfrancesco, L. Cordero di Montezemolo, and M.T. Di Tullio Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma J. Clin. Oncol. 11 1993 1770 1779
8. H.M. Katzenstein, S.L. Cohn, R.M. Shore, D.M. Bardo, P.R. Haut, and M. Olszewski Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma J. Clin. Oncol. 22 2004 3909 3915
9. J.D. de Certaines High resolution nuclear magnetic resonance spectroscopy in clinical biology: application in oncology Anticancer Res. 16 1996 1325 1331
10. 1H-MRS using water as an internal standard Magn. Reson. Imaging 11 1993 107 118
11. I.M. Burtscher, and S. Holtas Proton MR spectroscopy in clinical routine J. Magn. Reson. Imaging 13 2001 560 567
12. F. Podo Tumour phospholipid metabolism NMR Biomed. 12 1999 413 439
13. W. Negendank Studies of human tumors by MRS: a review NMR Biomed. 5 1992 303 324
14. F. Podo, and J.D. de Certaines Magnetic resonance spectroscopy in cancer: phospholipid, neutral lipid and lipoprotein metabolism and function Anticancer Res. 16 1996 1305 1315
15. C. Kettelhack, M. Wickede, T. Vogl, U. Schneider, and P. Hohenberger 31 Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors Cancer 94 2002 1557 1564
16. J.R. Griffiths, A.R. Tate, F.A. Howe, and M. Stubbs Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma Eur. J. Cancer 38 2002 2085 2093
17. J.M. Maris, A.E. Evans, A.C. McLaughlin, G.J. D'Angio, L. Bolinger, H. Manos, and B. Chance 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ N. Engl. J. Med. 312 1985 1500 1505
18. S.J. Vaidya, G.S. Payne, M.O. Leach, and C.R. Pinkerton Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer Eur. J. Cancer 39 2003 728 735
19. I.M. Burtscher, and S. Holtas Proton magnetic resonance spectroscopy in brain tumours: clinical applications Neuroradiology 43 2001 345 352
20. O. Warburg On respiratory impairment in cancer cells Science 124 1956 269 270
21. E. Ackerstaff, K. Glunde, and Z.M. Bhujwalla Choline phospholipid metabolism: a target in cancer cells? J. Cell Biochem. 90 2003 525 533
22. K.K. Bhakoo, S.R. Williams, C.L. Florian, H. Land, and M.D. Noble Immortalization and transformation are associated with specific alterations in choline metabolism Cancer Res. 56 1996 4630 4635
23. E.O. Aboagye, and Z.M. Bhujwalla Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res. 59 1999 80 84
24. T. Tamiya, K. Kinoshita, Y. Ono, K. Matsumoto, T. Furuta, and T. Ohmoto Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas Neuroradiology 42 2000 333 338
25. S. Herminghaus, U. Pilatus, W. Moller-Hartmann, P. Raab, H. Lanfermann, W. Schlote, and F.E. Zanella Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors NMR Biomed. 15 2002 385 392
26. K.E. Warren, J.A. Frank, J.L. Black, R.S. Hill, J.H. Duyn, and A.A. Aikin Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors J. Clin. Oncol. 18 2000 1020 1026
27. A.A. Tzika, L.G. Astrakas, M.K. Zarifi, D. Zurakowski, T.Y. Poussaint, and L. Goumnerova Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors Cancer 100 2004 1246 1256
28. J.S. Taylor, J.W. Langston, W.E. Reddick, P.B. Kingsley, R.J. Ogg, and M.H. Pui Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis Int. J. Radiat. Oncol. Biol. Phys. 36 1996 1251 1261
29. 1H NMR visible lipids in the life and death of cells Trends Biochem. Sci. 25 2000 357 362
30. M. Kaminogo, H. Ishimaru, M. Morikawa, M. Ochi, R. Ushijima, and M. Tani Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain Neuroradiology 43 2001 353 363
31. P.S. Murphy, I.J. Rowland, L. Viviers, M. Brada, M.O. Leach, and A.S. Dzik-Jurasz Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? Br. J. Radiol. 76 2003 459 463
32. J.S. Nelson, Y. Tsukada, D. Schoenfeld, K. Fulling, J. Lamarche, and N. Peress Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas Cancer 52 1983 550 554
33. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue NMR Biomed. 7 1994 149 155
34. L.L. Cheng, D.C. Anthony, A.R. Comite, P.M. Black, A.A. Tzika, and R.G. Gonzalez Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy Neuro-oncology 2 2000 87 95
35. W.G. Negendank, R. Sauter, T.R. Brown, J.L. Evelhoch, A. Falini, and E.D. Gotsis Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study J. Neurosurg. 84 1996 449 458
36. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis Nat. Med. 5 1999 1323 1327
37. F.G. Blankenberg, R.W. Storrs, L. Naumovski, T. Goralski, and D. Spielman Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy Blood 87 1996 1951 1956
38. T. Bezabeh, J.L. Evelhoch, P. Thompson, D.J. Sloop, and J.J. Ackerman Therapeutic efficacy as predicted by quantitative assessment of murine RIF-1 tumour pH and phosphorous metabolite response during hyperthermia: an in vivo 31P NMR study Int. J. Hyperther. 20 2004 335 357
39. N.M. Al-Saffar, J.C. Titley, D. Robertson, P.A. Clarke, L.E. Jackson, M.O. Leach, and S.M. Ronen Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells Br. J. Cancer 86 2002 963 970
40. 1H nuclear magnetic resonance correspond to lipid droplets Cancer Res. 57 1997 407 414
41. 1H NMR spectroscopy for three types of human brain and nervous system tumours NMR Biomed. 8 1995 253 264
42. M.L. Gyngell, T. Els, M. Hoehn-Berlage, and K.A. Hossmann Proton MR spectroscopy of experimental brain tumors in vivo Acta Neurochir. Suppl. (Wien) 60 1994 350 352
43. 1H MRS) Br. J. Cancer 88 2003 478 485
44. S. Zoula, G. Herigault, A. Ziegler, R. Farion, M. Decorps, and C. Remy Correlation between the occurrence of 1 H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development NMR Biomed. 16 2003 199 212
45. R. Katz-Brull, P.T. Lavin, and R.E. Lenkinski Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions J. Natl Cancer Inst. 94 2002 1197 1203
46. 1H NMR spectroscopy in extracranial lymphoma and germ cell tumours Br. J. Radiol. 75 2002 959 966
47. P. Lang, M.F. Wendland, M. Saeed, A. Gindele, W. Rosenau, A. Mathur, C.A. Gooding, and H.K. Genant Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging Radiology 206 1998 227 235
48. M. Uhl, C. Altehoefer, U. Kontny, K. Il'yasov, M. Buchert, and M. Langer MRI-diffusion imaging of neuroblastomas: first results and correlation to histology Eur. Radiol. 12 2002 2335 2338
49. M. Lindskog, C. Spenger, J. Jarvet, A. Graslund, and P. Kogner Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma J. Natl Cancer Inst. 96 2004 1457 1466
50. S.K. Roman, T.M. Jeitner, R. Hancock, W.A. Cooper, D.C. Rideout, and E.J. Delikatny Induction of magnetic resonance-visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride Int. J. Cancer 73 1997 570 579
51. 1H NMR visible lipids are induced by phosphonium salts and 5-fluorouracil in human breast cancer cells Magn. Reson. Med. 45 2001 1001 1010
52. J. Kurhanewicz, D.B. Vigneron, H. Hricak, F. Parivar, S.J. Nelson, K. Shinohara, and P.R. Carroll Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging Radiology 200 1996 489 496
53. N.R. Jagannathan, M. Kumar, V. Seenu, O. Coshic, S.N. Dwivedi, and P.K. Julka Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer Br. J. Cancer 84 2001 1016 1022
54. J.R. Allen, R.W. Prost, O.W. Griffith, S.J. Erickson, and B.A. Erickson In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma Am. J. Clin. Oncol. 24 2001 522 529
55. C.E. Mountford, S. Doran, C.L. Lean, and P. Russell Cancer pathology in the year 2000 Biophys. Chem. 68 1997 127 135
56. J.I. Johnsen, M. Lindskog, F. Ponthan, I. Pettersen, L. Elfman, A. Orrego, B. Sveinbjornsson, and P. Kogner Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo Cancer Res. 64 2004 7210 7215